文献
J-GLOBAL ID:201702245117246690
整理番号:17A0256829
乳癌感受性遺伝子1と受容体関連蛋白質80 MRNA発現レベルは肺癌患者個別化治療の多施設無作為対照臨床研究を指導する。【JST・京大機械翻訳】
Chinese multicenter randomized trial of customized chemotherapy based on BRCA1 (breast cancer susceptibility gene 1) -RAP80 (receptor-associated protein 80) mRNA expression in advanced non-small cell lung cancer (NSCLC) patients
著者 (17件):
Wei Jia
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
,
Qian Xiaoping
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
,
Zou Zhengyun
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
,
Wang Lifeng
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
,
Yu Lixia
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
,
You Chuanwen
(Department of Oncology, Suqian General Hospital)
,
Song Yong
(Department of Respiratory Medicine,Jinlin Hospital)
,
Lu Huiyu
(Department of Oncology, Taizhou General Hospital)
,
Hu Wenjing
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
,
Yan Jing
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
,
Xu Xingxiang
(Department of Respiratory Medicine, Northern Jiangsu People’s Hospital)
,
Chen Xiaofei
(Department of Oncology, Huaian General Hospital)
,
Li Xingya
(Department of Oncology, Affiliated Hospital to Zhengzhou University)
,
Wu Qinfang
(Department of Oncology, Yixing General Hospital)
,
Zhou Yan
(Department of Oncology, Yixing General Hospital)
,
Zhang Felling
(Department of Oncology, Maanshan General Hospital)
,
Liu Baorui
(The Comprehensive Cancer Center, Affiliated Drum Tower Hospital to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University)
資料名:
Zhonghua Zhongliu Zazhi
(Zhonghua Zhongliu Zazhi)
巻:
38
号:
11
ページ:
868-873
発行年:
2016年
JST資料番号:
C2345A
ISSN:
0253-3766
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
中国 (CHN)
言語:
中国語 (ZH)